Table 1.
Characteristic | Total | Responders After First Application | Responders After Second Application | Responders After Third Application | Others* |
---|---|---|---|---|---|
STRIDE | N = 306 | n = 60 | n = 33 | n = 11 | n = 202 |
Sex, female, n (%) | 132 (43.1) | 28 (46.7) | 19 (57.6) | 7 (63.4) | 78 (38.6) |
Age, years, mean ± SD | 57.9 ± 15.0 | 58.7 ± 15.8 | 60.5 ± 15.4 | 55.0 ± 13.1 | 57.3 ± 14.9 |
Peripheral NeP duration, years, mean ± SD | 5.1 ± 5.5 | 5.2 ± 5.5 | 4.4 ± 4.3 | 5.1 ± 5.9 | 5.2 ± 5.6 |
Baseline pain†, mean ± SD | 6.6 ± 1.4 | 6.3 ± 1.3 | 6.6 ± 1.1 | 6.1 ± 1.3 | 6.8 ± 1.5 |
PACE | N = 313 | n = 96 | n = 68 | n = 43 | n = 106 |
Sex, female, n (%) | 160 (51.1) | 54 (56.3) | 35 (51.5) | 20 (46.5) | 51 (48.1) |
Age, years, mean ± SD | 61.0 ± 10.6 | 58.9 ± 10.6 | 61.3 ± 11.8 | 61.6 ± 9.0 | 62.3 ± 10.2 |
Peripheral NeP duration, years, mean ± SD | 4.3 ± 3.8 | 4.5 ± 4.9 | 4.2 ± 3.5 | 3.7 ± 2.7 | 4.4 ± 3.1 |
Baseline pain†, mean ± SD | 5.6 ± 1.3 | 5.6 ± 1.2 | 5.6 ± 1.4 | 5.6 ± 1.1 | 5.6 ± 1.5 |
SD=standard deviation.
Includes nonresponders to first or second application who were not offered subsequent applications, as well as nonresponders to third application.
Assessed with question 5 of the BPI.